1-20 of 35
bortezomib
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Beyond plasma exchange: novel therapies for thrombotic thrombocytopenic purpura

Kathryn Dane, Shruti Chaturvedi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 539–547.
https://doi.org/10.1182/asheducation-2018.1.539
Published: 2018
Journal Articles

Fixed duration vs continuous therapy in multiple myeloma

Heinz Ludwig, Niklas Zojer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 212–222.
https://doi.org/10.1182/asheducation-2017.1.212
Published: 2017
Journal Articles

Management of multiple myeloma in the relapsed/refractory patient

Pieter Sonneveld
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 508–517.
https://doi.org/10.1182/asheducation-2017.1.508
Published: 2017
Journal Articles

Myeloma: management of the newly diagnosed high-risk patient

Angela Dispenzieri
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 485–494.
https://doi.org/10.1182/asheducation-2016.1.485
Published: 2016
Journal Articles

Sequencing of nontransplant treatments in multiple myeloma patients with active disease

Andrew J. Yee, Noopur S. Raje
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 495–503.
https://doi.org/10.1182/asheducation-2016.1.495
Published: 2016
Journal Articles

Maintenance therapy for multiple myeloma in the era of novel agents

Thierry Facon
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 279–285.
https://doi.org/10.1182/asheducation-2015.1.279
Published: 2015
Journal Articles

Novel combination approaches for myeloma

Sagar Lonial, Ajay K. Nooka
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 286–293.
https://doi.org/10.1182/asheducation-2015.1.286
Published: 2015
Journal Articles

Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange

Paul Coppo, Antoine Froissart
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 637–643.
https://doi.org/10.1182/asheducation-2015.1.637
Published: 2015
Journal Articles

Early or delayed transplantation for multiple myeloma in the era of novel therapy: does one size fit all?

Paul G. Richardson, Jacob P. Laubach, Nikhil C. Munshi, Kenneth C. Anderson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 255–261.
https://doi.org/10.1182/asheducation-2014.1.255
Published: 2014
Journal Articles

Multiple myeloma: a model for scientific and clinical progress

Jesus San Miguel
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 1–7.
https://doi.org/10.1182/asheducation-2014.1.1
Published: 2014
Journal Articles

How should we treat newly diagnosed multiple myeloma patients?

María-Victoria Mateos, Jesús F. San Miguel
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 488–495.
https://doi.org/10.1182/asheducation-2013.1.488
Published: 2013
Journal Articles

Strategies for induction, autologous hematopoietic stem cell transplantation, consolidation, and maintenance for transplantation-eligible multiple myeloma patients

Philip L. McCarthy, Theresa Hahn
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 496–503.
https://doi.org/10.1182/asheducation-2013.1.496
Published: 2013
Journal Articles

Have drug combinations supplanted stem cell transplantation in myeloma?

Antonio Palumbo, Federica Cavallo
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 335–341.
https://doi.org/10.1182/asheducation.V2012.1.335.3792205
Published: 2012
Journal Articles

Doublets, triplets, or quadruplets of novel agents in newly diagnosed myeloma?

S. Vincent Rajkumar
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 354–361.
https://doi.org/10.1182/asheducation.V2012.1.354.3798330
Published: 2012
Journal Articles

Many Multiple Myelomas: Making More of the Molecular Mayhem

Marta Chesi, P. Leif Bergsagel
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 344–353.
https://doi.org/10.1182/asheducation-2011.1.344
Published: 2011
Journal Articles

Posttransplantation Maintenance Therapy and Optimal Frontline Therapy in Myeloma

Donna E. Reece
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 197–204.
https://doi.org/10.1182/asheducation-2011.1.197
Published: 2011
Journal Articles

What is the Benefit of Maintenance Therapy with Lenalidomide or Bortezomib after Autologous Stem Cell Transplantation in Multiple Myeloma and What is the Risk of Developing a Secondary Primary Malignancy?

Emma Scott, Donna Reece
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 205–207.
https://doi.org/10.1182/asheducation-2011.1.205
Published: 2011
Journal Articles

Stem Cell Transplantation for Multiple Myeloma: Current and Future Status

Sergio Giralt
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 191–196.
https://doi.org/10.1182/asheducation-2011.1.191
Published: 2011
Journal Articles

Ultra High-Risk Myeloma

Hervé Avet-Loiseau
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 489–493.
https://doi.org/10.1182/asheducation-2010.1.489
Published: 2010
Journal Articles

Systemic Light-Chain Amyloidosis: Advances in Diagnosis, Prognosis, and Therapy

Adam D. Cohen, Raymond L. Comenzo
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 287–294.
https://doi.org/10.1182/asheducation-2010.1.287
Published: 2010